Literature DB >> 17939547

Azotemia and glomerular filtration rate in dogs with chronic valvular disease.

Audrey P Nicolle1, Valérie Chetboul, Till Allerheiligen, Jean-Louis Pouchelon, Vassiliki Gouni, Dominique Tessier-Vetzel, Carolina Carlos Sampedrano, Hervé P Lefebvre.   

Abstract

BACKGROUND: Little information is available about the prevalence of renal dysfunction in dogs with chronic valvular heart disease (CVD). HYPOTHESIS: Azotemia and a decrease in glomerular filtration rate (GFR) are more severe with increased severity of CVD. ANIMALS: 124 (study No. 1) and 24 (study No. 2) client-owned dogs with CVD.
METHODS: A retrospective study (study No. 1) was performed to assess the prevalence of azotemia in the New York Heart Association (NYHA) classes of heart failure in dogs with CVD. A prospective study (study No. 2) was then designed to determine GFR in dogs with different degrees of CVD severity. Complete physical examination, electrocardiography, blood pressure measurement, thoracic radiographs, echocardiography, and plasma and urine analyses were also performed.
RESULTS: In study No. 1, 50% of the dogs were azotemic and the percentage of azotemic dogs increased with functional class (up to 70% in NYHA class IV patients). In study No. 2, 8/24 dogs were azotemic. Plasma urea and creatinine were higher in NYHA class III-IV dogs compared with class I-II dogs. The GFR was lower (P < .001) in NYHA class III-IV dogs (1.7 +/- 0.7 mL/min/kg) than in class I to II dogs (3.1 +/- 0.8 mL/min/kg). Only 1 dog in class I-II had a GFR below 2 mL/min/kg and only 2/9 class III-IV dogs had a GFR above 2 mL/min/kg. CONCLUSION AND CLINICAL RELEVANCE: Azotemia and renal impairment increase with the severity of congestive heart failure and are frequent findings in dogs with CVD. It remains to be shown if deterioration of renal function is a direct result of progression of the heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939547     DOI: 10.1892/0891-6640(2007)21[943:aagfri]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  11 in total

Review 1.  An overview of glomerular filtration rate testing in dogs and cats.

Authors:  Vanessa E Von Hendy-Willson; Barrak M Pressler
Journal:  Vet J       Date:  2010-06-11       Impact factor: 2.688

2.  Canine pancreatic-specific lipase concentrations in dogs with heart failure and chronic mitral valvular insufficiency.

Authors:  D Han; R Choi; C Hyun
Journal:  J Vet Intern Med       Date:  2015-01-14       Impact factor: 3.333

3.  Prevalence and Prognosis of Anemia in Dogs with Degenerative Mitral Valve Disease.

Authors:  Ivarosa Bing-Ye Yu; Hui-Pi Huang
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

4.  Preliminary Investigation of Cardiovascular-Renal Disorders in Dogs with Chronic Mitral Valve Disease.

Authors:  E Martinelli; C Locatelli; S Bassis; S Crosara; S Paltrinieri; P Scarpa; I Spalla; A M Zanaboni; C Quintavalla; P Brambilla
Journal:  J Vet Intern Med       Date:  2016-09       Impact factor: 3.333

5.  Evaluation of serum cystatin-C and symmetric dimethylarginine concentrations in dogs with heart failure from chronic mitral valvular insufficiency.

Authors:  Bom-Sul Choi; Hyeong-Sun Moon; Sang-Hyuk Seo; Changbaig Hyun
Journal:  J Vet Med Sci       Date:  2016-09-30       Impact factor: 1.267

6.  Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker.

Authors:  Alice Savarese; Monica Probo; Chiara Locatelli; Sergio Aurelio Zanzani; Alessia Libera Gazzonis; Melissa Papa; Paola Giuseppina Brambilla
Journal:  Open Vet J       Date:  2018-08-19

7.  Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.

Authors:  Darcy Adin; Kari Kurtz; Clarke Atkins; Mark G Papich; Shelly Vaden
Journal:  J Vet Intern Med       Date:  2019-11-26       Impact factor: 3.333

8.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

9.  Comparison of pancreatic and renal blood flow in a canine tachycardia-induced cardiomyopathy model.

Authors:  Aritada Yoshimura; Takahiro Ohmori; Shusaku Yamada; Takae Kawaguchi; Miori Kishimoto; Tomoko Iwanaga; Naoki Miura; Ryuji Fukushima
Journal:  J Vet Med Sci       Date:  2020-04-24       Impact factor: 1.267

10.  Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy.

Authors:  Mengmeng Liu; Liza S Köster; Geoffrey T Fosgate; Christopher C Chadwick; Íñigo Sanz-González; Peter David Eckersall; Paul R Wotton; Anne T French
Journal:  J Vet Intern Med       Date:  2020-05-12       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.